Back
Top 0.2%
30.3%
Top 0.6%
11.6%
#1
9.5%
Top 2%
6.8%
Top 0.8%
6.8%
Top 0.4%
6.3%
Top 73%
2.9%
Top 89%
2.9%
Top 8%
2.1%
Top 1%
2.1%
Top 3%
2.1%
Top 4%
1.4%
Top 33%
1.4%
Top 56%
1.4%
Top 4%
1.4%
Top 49%
1.2%
Top 4%
1.0%
Top 22%
0.8%
Top 4%
0.8%
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMI
2026-02-09
cardiovascular medicine
Title + abstract only
View on medRxiv
Show abstract
BackgroundAmong patients with ST segment elevation myocardial infarction (STEMI), higher concentrations of high sensitivity troponin T (hs-cTnT) are associated with larger MI size and predict a worse prognosis. In the 2467 patient CELEBRATE trial, a single subcutaneous injection of the short-acting glycoprotein IIb/IIIa receptor blocker antagonist zalunfiban at first medical contact significantly improved the primary outcome including clinical endpoints. In this study, we assessed the impact of ...
Predicted journal destinations
1
Journal of the American Heart Association
92 training papers
2
Circulation
37 training papers
3
Open Heart
18 training papers
4
Frontiers in Cardiovascular Medicine
33 training papers
5
Circulation: Genomic and Precision Medicine
30 training papers
6
The American Journal of Cardiology
15 training papers
7
Scientific Reports
701 training papers
8
PLOS ONE
1737 training papers
9
Journal of Clinical Medicine
77 training papers
10
Atherosclerosis
16 training papers
11
Heart Rhythm
16 training papers
12
European Heart Journal - Digital Health
15 training papers
13
eLife
262 training papers
14
BMJ Open
553 training papers
15
Hypertension
20 training papers
16
Nature Communications
483 training papers
17
Medicine
29 training papers
18
PLOS Medicine
95 training papers
19
Frontiers in Physiology
18 training papers